The UK has approved a fifth Covid-19 vaccine, developed by US company Novavax
I’m Paul Hutton keeping you up to date with news that the UK has approved a fifth Covid-19 vaccine, developed by US company Novavax, which appears to offer up to 89% protection against Covid illness. The Medicines and Healthcare products Regulatory Agency has said it is safe as a first and second dose in adults. Millions of doses are being manufactured at a plant on Teesside. The vaccine could then be used immediately as part of the UK vaccination programme. We’ll keep you up to date on this and other developments, here on Care Radio